• Skip to main content
Checkmate Pharmaceuticals
  • Publications & Resources
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • Financials
      • SEC Filings
    • Investor Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts
  • Careers
  • Contact
  • Our Story
  • Our Science
    • Vidutolimod Platform/Technology
    • Mechanism of Action
    • Pipeline
    • Glossary of Terms
  • Our Difference
  • Our People
    • Leadership
    • Board of Directors
  • Clinical Trials
    • Melanoma
    • HNSCC
    • Non-melanoma
    • Expanded Access Policy
  • Publications & Resources
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • Financials
      • SEC Filings
    • Investor Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts
  • Careers
  • Contact

We Want to Hear From You

Checkmate Pharmaceuticals
245 Main Street, 2nd Floor
Cambridge, MA 02142

For Partnering and Media Inquiries
Please contact:
communications@checkmatepharma.com

For Information on Our Ongoing Clinical Trials
Please contact:
clinicaltrials@checkmatepharma.com

For Other Inquiries
Please contact:
admin@checkmatepharma.com

Contact Us   I   Privacy Policy

Checkmate Pharmaceuticals   I   245 Main Street, 2nd Floor   I   Cambridge, MA 02142
617.682.3625
admin@checkmatepharma.com

©2021 Checkmate Pharmaceuticals. All rights reserved. Created in the USA. CMP-WEB-001-01 07/2021